WuXi XDC Cayman, Inc. (HK:2268) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
WuXi XDC Cayman Inc. has announced a further delay in sending out the Circular to shareholders, which includes details of the Antibodies Master Services Agreement and the Revised Annual Caps related to it. The Circular, initially expected by September 30, 2024, will now be dispatched by October 11, 2024, due to the need for additional time to prepare certain information. This postponement follows previous delays communicated by the company in August and September 2024.
For further insights into HK:2268 stock, check out TipRanks’ Stock Analysis page.